Logo image of SNEX

STONEX GROUP INC (SNEX) Stock Fundamental Analysis

NASDAQ:SNEX - Nasdaq - US8618961085 - Common Stock - Currency: USD

91.44  -4.91 (-5.1%)

After market: 91.44 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SNEX. SNEX was compared to 233 industry peers in the Capital Markets industry. SNEX has a bad profitability rating. Also its financial health evaluation is rather negative. SNEX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

SNEX had positive earnings in the past year.
SNEX had a negative operating cash flow in the past year.
In the past 5 years SNEX has always been profitable.
In multiple years SNEX reported negative operating cash flow during the last 5 years.
SNEX Yearly Net Income VS EBIT VS OCF VS FCFSNEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

SNEX's Return On Assets of 0.91% is on the low side compared to the rest of the industry. SNEX is outperformed by 66.95% of its industry peers.
SNEX's Return On Equity of 15.19% is fine compared to the rest of the industry. SNEX outperforms 77.68% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.52%, SNEX is doing worse than 67.81% of the companies in the same industry.
SNEX had an Average Return On Invested Capital over the past 3 years of 2.05%. This is significantly below the industry average of 7.84%.
Industry RankSector Rank
ROA 0.91%
ROE 15.19%
ROIC 1.52%
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
SNEX Yearly ROA, ROE, ROICSNEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 0.23%, SNEX is not doing good in the industry: 72.96% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of SNEX has remained more or less at the same level.
SNEX has a worse Operating Margin (0.32%) than 73.82% of its industry peers.
SNEX's Operating Margin has been stable in the last couple of years.
SNEX's Gross Margin of 1.97% is on the low side compared to the rest of the industry. SNEX is outperformed by 72.96% of its industry peers.
SNEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.32%
PM (TTM) 0.23%
GM 1.97%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
SNEX Yearly Profit, Operating, Gross MarginsSNEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, SNEX has more shares outstanding
Compared to 5 years ago, SNEX has more shares outstanding
Compared to 1 year ago, SNEX has a worse debt to assets ratio.
SNEX Yearly Shares OutstandingSNEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
SNEX Yearly Total Debt VS Total AssetsSNEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

SNEX has an Altman-Z score of 3.68. This indicates that SNEX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.68, SNEX belongs to the top of the industry, outperforming 80.26% of the companies in the same industry.
A Debt/Equity ratio of 7.19 is on the high side and indicates that SNEX has dependencies on debt financing.
SNEX's Debt to Equity ratio of 7.19 is on the low side compared to the rest of the industry. SNEX is outperformed by 87.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.19
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACCN/A
WACCN/A
SNEX Yearly LT Debt VS Equity VS FCFSNEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.52 indicates that SNEX may have some problems paying its short term obligations.
The Current ratio of SNEX (0.52) is worse than 74.68% of its industry peers.
SNEX has a Quick Ratio of 0.52. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX has a Quick ratio of 0.52. This is in the lower half of the industry: SNEX underperforms 74.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
SNEX Yearly Current Assets VS Current LiabilitesSNEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

6

3. Growth

3.1 Past

SNEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.07%, which is quite good.
SNEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.13% yearly.
The Revenue has grown by 67.71% in the past year. This is a very strong growth!
Measured over the past years, SNEX shows a very strong growth in Revenue. The Revenue has been growing by 24.87% on average per year.
EPS 1Y (TTM)18.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%29.75%
Revenue 1Y (TTM)67.71%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%49.48%

3.2 Future

SNEX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.48% yearly.
The Revenue is expected to grow by 2.62% on average over the next years.
EPS Next Y12%
EPS Next 2Y6.15%
EPS Next 3Y5.48%
EPS Next 5YN/A
Revenue Next Year7.01%
Revenue Next 2Y3.55%
Revenue Next 3Y2.62%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNEX Yearly Revenue VS EstimatesSNEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
SNEX Yearly EPS VS EstimatesSNEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.50 indicates a correct valuation of SNEX.
Compared to the rest of the industry, the Price/Earnings ratio of SNEX is on the same level as its industry peers.
When comparing the Price/Earnings ratio of SNEX to the average of the S&P500 Index (27.30), we can say SNEX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 15.29, SNEX is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as SNEX.
When comparing the Price/Forward Earnings ratio of SNEX to the average of the S&P500 Index (21.76), we can say SNEX is valued slightly cheaper.
Industry RankSector Rank
PE 15.5
Fwd PE 15.29
SNEX Price Earnings VS Forward Price EarningsSNEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNEX indicates a rather cheap valuation: SNEX is cheaper than 90.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.86
SNEX Per share dataSNEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.29
PEG (5Y)0.7
EPS Next 2Y6.15%
EPS Next 3Y5.48%

0

5. Dividend

5.1 Amount

No dividends for SNEX!.
Industry RankSector Rank
Dividend Yield N/A

STONEX GROUP INC

NASDAQ:SNEX (7/11/2025, 8:00:02 PM)

After market: 91.44 0 (0%)

91.44

-4.91 (-5.1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners82.48%
Inst Owner Change0%
Ins Owners10.11%
Ins Owner Change11.28%
Market Cap4.47B
Analysts87.5
Price Target104.04 (13.78%)
Short Float %2.37%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.79%
Min EPS beat(2)4.76%
Max EPS beat(2)14.81%
EPS beat(4)4
Avg EPS beat(4)8.49%
Min EPS beat(4)3.43%
Max EPS beat(4)14.81%
EPS beat(8)8
Avg EPS beat(8)11.57%
EPS beat(12)11
Avg EPS beat(12)13.14%
EPS beat(16)13
Avg EPS beat(16)15.34%
Revenue beat(2)2
Avg Revenue beat(2)1.2%
Min Revenue beat(2)0.48%
Max Revenue beat(2)1.92%
Revenue beat(4)3
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-3.69%
Max Revenue beat(4)6.22%
Revenue beat(8)5
Avg Revenue beat(8)-1.53%
Revenue beat(12)9
Avg Revenue beat(12)1100.01%
Revenue beat(16)13
Avg Revenue beat(16)1890.17%
PT rev (1m)22.89%
PT rev (3m)19.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.91%
EPS NY rev (1m)0%
EPS NY rev (3m)0.47%
Revenue NQ rev (1m)4.18%
Revenue NQ rev (3m)1.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 15.5
Fwd PE 15.29
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 2.38
P/tB 2.5
EV/EBITDA 8.86
EPS(TTM)5.9
EY6.45%
EPS(NY)5.98
Fwd EY6.54%
FCF(TTM)-23.01
FCFYN/A
OCF(TTM)-21.7
OCFYN/A
SpS2515.02
BVpS38.47
TBVpS36.63
PEG (NY)1.29
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 15.19%
ROCE 6.01%
ROIC 1.52%
ROICexc 1.63%
ROICexgc 1.75%
OM 0.32%
PM (TTM) 0.23%
GM 1.97%
FCFM N/A
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
ROICexc(3y)2.29%
ROICexc(5y)1.95%
ROICexgc(3y)2.5%
ROICexgc(5y)2.13%
ROCE(3y)6.36%
ROCE(5y)5.86%
ROICexcg growth 3Y11.83%
ROICexcg growth 5Y4.45%
ROICexc growth 3Y11.82%
ROICexc growth 5Y4.25%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
F-Score4
Asset Turnover3.93
Health
Industry RankSector Rank
Debt/Equity 7.19
Debt/FCF N/A
Debt/EBITDA 27.95
Cap/Depr 72.81%
Cap/Sales 0.05%
Interest Coverage 0.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 3.68
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)80.55%
Cap/Depr(5y)85.05%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%29.75%
EPS Next Y12%
EPS Next 2Y6.15%
EPS Next 3Y5.48%
EPS Next 5YN/A
Revenue 1Y (TTM)67.71%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%49.48%
Revenue Next Year7.01%
Revenue Next 2Y3.55%
Revenue Next 3Y2.62%
Revenue Next 5YN/A
EBIT growth 1Y20.39%
EBIT growth 3Y31.11%
EBIT growth 5Y26.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.25%
FCF growth 3Y-40.15%
FCF growth 5Y19.18%
OCF growth 1Y63.81%
OCF growth 3Y-37.96%
OCF growth 5Y20.98%